Bestzyme

Nanjing Bestzyme Bioengineering Co., Ltd. (Bestzyme), one of GenScript Biotech's subsidiaries, is a hi-tech enterprise integrating research, development, production and sales of industrial enzyme products and APIs. Dedicated to synthetic biology technology, Bestzyme has established a fully integrated end-to-end system from molecule design and screening, genetic engineering, strain construction, process development, scaled up production, application development to technical support and sales. Established in 2013, Bestzyme is committed to driving innovation through independent R&D, core technology advancement and full ownership of intellectual property rights. Bestzyme has since then successfully developed pullulanase, glucose oxidase, thermostable amylase, protease and other enzymes for industrial, feed, food and pharmaceutical use with independent intellectual property rights, offering a complete product portfolio with leading performance trusted by customers across multiple industries. In 2022, Bestzyme has launched enzyme products including new acid amylase and detergent protease, as well as muramidase, protease and a variety of compound enzyme products for feed. Using biosynthesis approach, Bestzyme has developed a new enzymatic process in replacement of a traditionally chemical production process, which significantly improves yield, reduces chemical use and pollution, realizing green manufacturing together with partners. Bestzyme adheres to its mission of "making the world’s best enzymes". With leading products and advanced technology platforms, Bestzyme will work with customers and partners to upgrade industry technology, develop clean and green manufacturing processes towards a better future together.